MedTrace Logo

Evaluation of Cutaneous and Circulating Inflammatory Biomarkers in Hidradenitis Suppurativa and Atopic Dermatitis

NCT04440410 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2021-04-13

No results posted yet for this study

Summary

This non-intervention study will identify the biomarker profiles in hidradenitis suppurativa (HS) and atopic dermatitis (AD) (as a comparator) that would have the most utility in interventional studies evaluating efficacy during therapeutic intervention. Study data will also be used to correlate cellular/molecular changes in blood (cells and serum), and tissue, with clinical/histopathological phenotypes.

Conditions

Sponsors & Collaborators

  • York Dermatology Clinic and Research Centre

    collaborator UNKNOWN

  • Kymera Therapeutics, Inc.

    lead INDUSTRY

Principal Investigators

  • Afsaneh Alavi, MD · York Dermatology Clinic and Research Centre

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-28
Primary Completion
2021-03-24
Completion
2021-03-24

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04440410 on ClinicalTrials.gov